Abstract
We report a patient with metachronous bilateral breast cancer who has twice developed radiation pneumonitis after breast-conserving therapy for each breast. The patient was a 48-year-old woman, who presented with Stage I right breast cancer. After wide excision of the right breast tumor and dissection of level I axillary lymph nodes, systemic therapy with oral 5-FU and tamoxifen was started. Subsequently, tangential irradiation with a total dose of 50 Gy in 25 fractions was given. Seven months after irradiation, she developed respiratory symptoms and radiation pneumonitis was diagnosed. The symptoms resolved with oral prednisolone. Thirty months after the right breast cancer treatment, Stage I left breast cancer was diagnosed. After wide excision of the left breast tumor and partial removal of the level I axillary lymph nodes, the same oral systemic chemo-hormonal therapy was initiated. Thereafter, tangential irradiation with a total dose of 50 Gy in 25 fractions was given. Four months after irradiation, she developed respiratory symptoms. A chest X-ray showed an area of increased density in the left lung consistent with radiation pneumonitis. The symptoms were mild and they improved spontaneously without medication. Although there is insufficient evidence to justify or withhold whole breast radiation therapy from patients with a history of contralateral breast cancer and radiation pneumonitis, it is essential to discuss the adequacy of whole breast irradiation and the possibility of alternative approaches, such as breast-conserving surgery without irradiation or partial breast irradiation for this rare condition.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Fung MC, Schultz DJ, Solin IJ: Early-stage bilateral breast cancer treated with breast-conserving surgery and definitive irradiation: the University of Pennsylvania experience.Int J Radiat Oncol Biol Phys 38:959–967, 1997.
Heaton KM, Peoples GE, Singletary SE, Feig BW, Ross MI, Ames FC, Buchholz TA, Strom EA, Mc-Neese MD, Hunt KK: Feasibility of breast conservation therapy in metachronous or synchronous bilateral breast cancer.Ann Surg Oncol 6:102–108, 1999.
Lind PA, Marks LB, Hardenbergh PH, Clough R, Fan M, Hollis D, Hernando ML, Lucas D, Piepgrass A, Prosnitz LR: Technical factors associated with radiation pneumonitis after local ± regional radiation therapy for breast cancer.Int J Radiat Oncol Biol Phys 52:137–143, 2002.
Lingos TI, Recht A, Vicini F, Abner A, Silver B, Harris JR: Radiation pneumonitis in breast cancer patients treated with conservative surgery and radiation therapy.Int J Radiat Oncol Biol Phys 21:355–360, 1991.
Fowble B, Fein DA, Hanlon AL, Eisenberg BL, Hoffman JP, Sigurdson ER, Daly MB, Goldstein LJ: The impact of tamoxifen on breast recurrence, cosmesis, complications, and survival in estrogen receptor-positive early-stage breast cancer.Int J Radiat Oncol Biol Phys 35:669–677, 1996.
Wennberg B, Gagliardi G, Sundbom L, Svane G, Lind P: Early response of lung in breast cancer irradiation: radiologic density changes measured by CT and symptomatic radiation pneumonitis.Int J Radiat Oncol Biol Phys 52:1196–1206, 2002.
Rancati T, Ceresoli GL, Gagliardi G, Schipani S, Cattaneo GM: Factors predicting radiation pneumonitis in lung cancer patients: a retrospective study.Radiother Oncol 67:275–283, 2003.
Robnett TJ, Machtay M, Vines EF, McKenna MG, Algazy KM, McKenna WG: Factors predicting severe radiation pneumonitis in patients receiving definitive chemoradiation for lung cancer.Int J Radiat Oncol Biol Phys 48:89–94, 2000.
Vinh-Hung V, Verschraegen C: Breast-conserving surgery with or without radiotherapy: pooled-analysis for risks of ipsilateral breast tumor recurrence and mortality.J Natl Cancer Inst 96:115–121, 2004.
Clark RM, Whelan T, Levine M, Roberts R, Willan A, McCulloch P, Lipa M, Wilkinson RH, Mahoney LJ: Randomized clinical trial of breast irradiation following lumpectomy and axillary dissection for node-negative breast cancer: an update. Ontario Clinical Oncology Group.J Natl Cancer Inst 88:1659–1664, 1996.
Lagios MD: Breast conservation without irradiation for invasive disease: legendary quest or definable reality?Ann Surg Oncol 7:552–553, 2000.
Schnitt SJ, Hayman J, Gelman R, Eberlein TJ, Love SM, Mayzel K, Osteen RT, Nixon AJ, Pierce S, Connolly JL, Cohen P, Schneider L, Silver B, Recht A, Harris JR: A prospective study of conservative surgery alone in the treatment of selected patients with stage I breast cancer.Caracer 77:1094–1100, 1996.
Crestani B, Kambouchner M, Soler P, Crequit J, Brauner M, Battesti JP, Valeyre D: Migratory bronchiolitis obliterans organizing pneumonia after unilateral radiation therapy for breast carcinoma.Eur Respir 78:318–321, 1995.
Takigawa N, Segawa Y, Saeki T, Kataoka M, Ida M, Kishino D, Fujiwara K, Ohsumi S, Eguchi K, Takashima S: Bronchiolitis obliterans organizing pneumonia syndrome in breast-conserving therapy for early breast cancer: radiation-induced lung toxicity.Int J Radiat Oncol Biol Phys 48:751–755, 2000.
Vicini F, Arthur D, Polgar C, Kuske R: Defining the efficacy of accelerated partial breast irradiation: the importance of proper patient selection, optimal quality assurance, and common sense.Int J Radiat Oncol Biol Phys 57:1210–1213, 2003.
Ribeiro GG, Magee B, Swindell R, Harris M, Banerjee SS: The Christie Hospital breast conservation trial: an update at 8 years from inception.Clin Oncol (R Coll Radiol) 5:278–283, 1993.
Author information
Authors and Affiliations
About this article
Cite this article
Narabayashi, M., Mitsumori, M., Araki, N. et al. A case of metachronous bilateral Breast Cancer with bilateral radiation pneumonitis after breast-conserving therapy. Breast Cancer 13, 313–316 (2006). https://doi.org/10.2325/jbcs.13.313
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.2325/jbcs.13.313